Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)-

Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- manufacturers

Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Basic information
Product Name:Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)-
Synonyms:Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)-;THR-β agonist 3
CAS:2656400-84-7
MF:C29H32ClO5P
MW:526.99
EINECS:
Product Categories:
Mol File:2656400-84-7.mol
Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Structure
Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Chemical Properties
Boiling point 668.3±55.0 °C(Predicted)
density 1.31±0.1 g/cm3(Predicted)
Safety Information
MSDS Information
Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Usage And Synthesis
UsesTHR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1].
References[1] Li Peng, et al. Benzo-fused ring compounds. Patent WO2021129827A1.
Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Preparation Products And Raw materials
Tag:Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)-(2656400-84-7) Related Product Information
trans-(S)-2-[[3,5-Dimethyl-4-(4-hydroxy-3-isopropylbenzyl)phenoxy]methyl]-4-(3-chlorophenyl)-2-oxo-[1,3,2]dioxaphosphorinane Phenol, 4-[[4-[[(2S,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-2-yl]methoxy]-2,6-dimethylphenyl]methyl]-2-(1-methylethyl)- MB 07811 Phenol, 4-[(1R)-5-[[(R)-[(2R,4S)-4-(3-chlorophenyl)-2-oxido-1,3,2-dioxaphosphorinan-1-yl][(2R,6S)-2-oxido-1,3,2-dioxaphosphorinan-3-yl]phosphinyl]methoxy]-2,3-dihydro-7-methyl-1H-inden-1-yl]-2-(1-methylethyl)- Iopanoic acid QRX 431